World first pancreatic cancer clinical trial starts at Subiaco
St John of God Subiaco Hospital Oncologist Dr Andrew Dean and patient Graeme Zorn. Photo: Supplied.
St John of God Subiaco Hospital is the first facility in the world to offer patients a new drug to help treat pancreatic cancer as a part of a world-first inhuman clinical trial.
Oncologist Dr Andrew Dean is leading the CEND-1 trial at St John of God Subiaco Hospital with the first two patients in the world starting treatment with the trial drug in September 2018.
“We are the first in the world to trial this brand new drug which hijacks a protein that the cancer cells